Veracyte said that the researchers, who had inconclusive results following bronchoscopy, a common nonsurgical procedure to diagnose lung cancer, have validated the Percepta GSC on 412 patients with
More From BioPortfolio on "Veracyte unveils Percepta Genomic Sequencing Classifier for lung cancer diagnosis"